Record Sales in Q4 2012

Medistim delivers record sales in Q4 2012 with MNOK 49.7 (MNOK 41.3). Strong growth of 13.6% for the full year, reaching MNOK 183.8 (MNOK 161.8).

Operating profit (EBIT) for the quarter was MNOK 6.1 (MNOK 3.7). Record operating profit for the full year 2012 with MNOK 41.1 (MOK 23.9).

Read the Q4 report  and the Finacial Presentation 2012 Q4:

4 quarter 2012 presentation_final >>
PDF: 4th quarter report 2012 >>